Prevention

In addition give or octreotide (50 micrograms subcutaneously twice daily for 6 months). ^a

Why?

• It reduces rebleeding and death. ^a

Octreotide combined with sclerotherapy helps reduce recurrent bleeding and death

Patient	Treatment	Comparison	Outcome	CER	RRR (95% CI)	NNT (95% CI)
recent first variceal bleed a	sclerotherapy and octreotide	sclerotherapy	recurrent variceal bleed at 6 months	32%	86% (-3% to 98%)	3 (2 to 10)
			death at 6 months	32%	100%	3 (2 to 12)